Baes M, Gressens P, Huyghe S, et al (2002) The neuronal migration defect in mice with
Zellweger syndrome (Pex5 knockout) is not caused by the inactivity of peroxisomal
beta-oxidation. J Neuropathol Exp Neurol 61: 368374.
Baptista CA, Hatten ME, Blazeski R, Mason CA (1994) Cell-cell interactions in£uence survival
and di¡erentiation of puri¢ed Purkinje cells in vitro. Neuron 12: 243260.
Bradke F, Dotti CG (1997) Neuronal polarity: vectorial cytoplasmic £ow precedes axon
formation. Neuron 19: 11751186.
Dobyns WB, Truwit CL (1995) Lissencephaly and other malformations of cortical
development: 1995 update. Neuropediatrics 26: 132147.
Dusart I, Airaksinen MS, Sotelo C (1997) Purkinje cell survival and axonal regeneration are age
dependent: An in vitro study. J Neurosci 17: 37103726.
Edmondson JC, Hatten ME (1987) Glial-guided granule neuron migration in vitro: a
high-resolution time-lapse video microscopic study. J Neurosci 7: 19281934.
Evrard P, Caviness VS, Prats-Vinas J, Lyon G (1978) The mechanism of arrest of neuronal
migration in the Zellweger malformation: an hypothesis based on cytoarchitectonic analysis.
Acta Neuropathol (Berl) 41: 109117.
Faust (2003) Abnormal cerebellar histogenesis in PEX2 Zellweger mice re£ects multiple
neuronal defects induced by peroxisome de¢ciency. J Comp Neurol 461: 394413.
Faust PL, Hatten ME (1997) Targeted deletion of the PEX2 peroxisome assambly gene in mice
provides a model for Zellweger syndrome, a human neuronal migration disorder. J Cell Biol
139: 12931305.
Faust PL, Su H-M, Moser A, Moser HW (2001) The peroxisome de¢cient PEX2 Zellweger
mouse: pathologic and biochemical correlates of lipid dysfunction. J Mol Neurosci 16:
289297.
Fujiki Y (2000) Peroxisome biogenesis and peroxisome biogenesis disorders. FEBS Lett 476:
4246.
Gould SJ, Valle D (2000) Peroxisome biogenesis disorders: genetics and cell biology. Trends
Genet 16: 340345.
Gould SJ, Raymond GV, Valle D (2001) The peroxisome biogenesis disorders. In Scriver CR,
Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The
Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill,
31813217.
Hatten ME, Mason CA (1990) Mechanisms of neural patterning and speci¢cation in the
developing cerebellum. Annu Rev Neurosci 18: 385408.
Heuer H, Mason CA (2003) Thyroid hormone induces cerebellar Purkinje cell dendritic development via the thyroid hormone receptor alpha1. J Neurosci 23: 1060410612.
Ito M (1984) Purkinje cells: abnormal morphology. The Cerebellum and Neural Control. New
York: Raven Press, 4050.
Janssen A, Baes M, Gressens P, Mannaerts GP, Declercq P, Van Veldhoven PP (2000)
Docosahexaenoic acid de¢cit is not a major pathogenic factor in peroxisome-de¢cient mice.
Lab Invest 80: 3135.
Janssen A, Gressens P, Grabenbauer M, et al (2003) Neuronal migration depends on intact
peroxisomal function in brain and in extraneuronal tissues. J Neurosci 23: 97329741.
Kaufmann WE, Theda C, Naidu S, Watkins PA, Moser AB, Moser HW (1996) Neuronal
migration abnormality in peroxisomal bifunctional enzyme defect. Ann Neurol 39: 268271.
Li X, Baumgart E, Morrell JC, Jimenez-Sanchez G, Valle D, Gould SJ (2002) PEX11 beta
de¢ciency is lethal and impairs neuronal migration but does not abrogate peroxisome
function. Mol Cell Biol 22: 43584365.
Maeda K, Kimura A, Yamato Y, et al (2002) Oral bile acid treatment in two Japanese patients
with Zellweger syndrome. J Pediatr Gastroenterol Nutr 35: 227230.
Maxwell M, Bjorkman J, Nguyen T, et al (2003) PEX13 inactivation in the mouse disrupts
peroxisome biogenesis and leads to a Zellweger phenotype. Mol Cell Biol 23: 59475957.
McKenna O, Arnold G, Holtzman E (1976) Microperoxisome distribution in the central nervous system of the rat. Brain Res 117: 181194.
